Literature DB >> 8997448

The changing panorama of cerebral palsy--bilateral spastic forms in particular.

B Hagberg1, G Hagberg.   

Abstract

Our Swedish population-based cerebral palsy (CP) project started 25 years ago and today covers the birth years 1954-1990, with over 1400 CP cases. This large series (1, 2, 3) has opened new perspectives on time trends and aetiological background factors, where two areas of successively increasing knowledge stand out as particularly helpful. One is the growing amount of biological and clinical data from the continuously increasing cohorts of surviving very preterm infants, the other is the rapidly expanding and refined information from neuroimaging. Bilateral spastic CP (BSCP), including spastic and ataxic diplegia, tetraplegia and spastic-dyskinetic CP, is the most prevalent clinical group of CP syndromes, present in around 75% of preterm and 45% of term CP, and has shown the most significant prevalence changes over time. In this presentation we, therefore, focus on BSCP, also analysed in a collaborative study between southwest Germany and western Sweden and recently presented in a series of four papers (4, 5, 6, 7).

Entities:  

Mesh:

Year:  1996        PMID: 8997448     DOI: 10.1111/j.1651-2227.1996.tb14277.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  8 in total

Review 1.  Synergistic neuroprotective therapies with hypothermia.

Authors:  Maria Roberta Cilio; Donna M Ferriero
Journal:  Semin Fetal Neonatal Med       Date:  2010-03-07       Impact factor: 3.926

Review 2.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

3.  Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain.

Authors:  V Laudenbach; G Calo; R Guerrini; G Lamboley; J F Benoist; P Evrard; P Gressens
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Prevalence of cerebral palsy in The Netherlands (1977-1988).

Authors:  M J Wichers; Y T van der Schouw; K G Moons; H J Stam; O van Nieuwenhuizen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

5.  Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.

Authors:  Ya-Jie Wang; Bao-Qin Gao
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

6.  Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation.

Authors:  Atsuyoshi Shimada; Sanae Hasegawa-Ishii
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

7.  Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study.

Authors:  Hannah Blencowe; Theo Vos; Anne C C Lee; Rachel Philips; Rafael Lozano; Miriam R Alvarado; Simon Cousens; Joy E Lawn
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

Review 8.  Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010.

Authors:  Hannah Blencowe; Anne C C Lee; Simon Cousens; Adil Bahalim; Rajesh Narwal; Nanbert Zhong; Doris Chou; Lale Say; Neena Modi; Joanne Katz; Theo Vos; Neil Marlow; Joy E Lawn
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.